NLK is a novel therapeutic target for PTEN deficient tumour cells.
PTEN (Phosphatase and tensin homolog) is a tumour suppressor gene commonly defective in human cancer, and is thus a potentially important therapeutic target. Targeting tumour suppressor loss-of-function is possible by exploiting the genetic concept of synthetic lethality (SL). By combining the use o...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2012
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/6b1c5800cf294b4893d83204f84bf90b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|